PBAX
NASDAQPhoenix Biotech Acquisition Corp.
Latest news
25 items- SECPhoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Filer)
- SECPhoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)8-K/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Filer)
- INSIDERNew insider Corey Daniel claimed ownership of 671,470 shares (SEC Form 3) (Amendment)3/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- SECSEC Form D filed by Phoenix Biotech Acquisition Corp.D - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Filer)
- 13D/GSEC Form SC 13G/A filed by Phoenix Biotech Acquisition Corp. (Amendment)SC 13G/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)
- INSIDERSEC Form 4 filed by Laporte Kathleen (Amendment)4/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDERAtwood Brian G acquired 248,735 shares (SEC Form 4) (Amendment)4/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- 13D/GSEC Form SC 13D/A filed by Phoenix Biotech Acquisition Corp. (Amendment)SC 13D/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)
- INSIDERLoewy Caroline M acquired 5,828 shares (SEC Form 4)4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDERKosacz Barbara acquired 5,828 shares (SEC Form 4)4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDERGeffken Daniel E. acquired 10,002 shares (SEC Form 4)4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDERFisher Douglas Carl acquired 43,300 shares (SEC Form 4)4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDERPhoenix Biotech Sponsor, Llc disposed of 5,296,246 shares, decreasing direct ownership by 81% to 1,000,000 units (SEC Form 4)4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDERLaporte Kathleen acquired 5,828 shares (SEC Form 4)4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDEREhrlich Christopher B disposed of 5,296,246 shares and acquired 482,425 shares (SEC Form 4)4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDERAtwood Brian G acquired 373,735 shares (SEC Form 4)4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDERSEC Form 3 filed by new insider Rolfe Lindsey3 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDERNew insider Rapaport Robyn claimed ownership of 50,000 shares (SEC Form 3)3 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDERNew insider Corey Daniel claimed ownership of 694,031 shares (SEC Form 3)3 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDERSEC Form 3 filed by new insider Carter Charles Ross3 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- INSIDERSEC Form 3 filed by new insider Byrnes Michael3 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
- SECSEC Form 25-NSE filed by Phoenix Biotech Acquisition Corp.25-NSE - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)
- PRPhoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business CombinationPhoenix Biotech Acquisition Corp. (NASDAQ:PBAX) ("PBAX") and CERo Therapeutics, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms ("CERo") today announced that their previously announced business combination has closed, resulting in CERo becoming a publicly-traded company. In connection with the consummation of the business combination, the combined public company was renamed "CERo Therapeutics Holdings, Inc." The shares of common stock of the combined public company have been approved for listing on the Nasdaq Global Market and are expected to commence trading under the ticker symbol "CERO" t
- SECSEC Form 425 filed by Phoenix Biotech Acquisition Corp.425 - PHOENIX BIOTECH ACQUISITION CORP. (0001870404) (Subject)
- SECPhoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - PHOENIX BIOTECH ACQUISITION CORP. (0001870404) (Filer)
PBAX FAQ
6 questionsWhat does Phoenix Biotech Acquisition Corp. do?
Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the life sciences sector. The company was incorporated in 2021 and is based in Oakland, California.Where does PBAX stock trade?
Phoenix Biotech Acquisition Corp. (PBAX) is listed on NASDAQ.What sector and industry is PBAX in?
Phoenix Biotech Acquisition Corp. operates in the Industrials sector, Consumer Electronics/Appliances industry.When did Phoenix Biotech Acquisition Corp. go public?
Phoenix Biotech Acquisition Corp. (PBAX) completed its IPO in 2021.What companies are similar to PBAX?
Notable peers in the same industry include GE (GE Aerospace), SONY (Sony Group Corporation), EMR (Emerson Electric Company), OTIS (Otis Worldwide Corporation), SN (SharkNinja Inc.). Compare PBAX side-by-side with any of them on Quantisnow.How can I track PBAX on Quantisnow?
Quantisnow aggregates Phoenix Biotech Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PBAX to receive live email and push alerts on every new disclosure.